This company has been marked as potentially delisted and may not be actively trading. Interpace Biosciences (IDXG) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsEarningsHeadlinesShort InterestTrendsBuy This Stock IDXG vs. LH, DGX, DVA, CHE, CRVL, AMED, MD, AMN, CCRN, and BTCYShould you be buying Interpace Biosciences stock or one of its competitors? The main competitors of Interpace Biosciences include Labcorp (LH), Quest Diagnostics (DGX), DaVita (DVA), Chemed (CHE), CorVel (CRVL), Amedisys (AMED), Pediatrix Medical Group (MD), AMN Healthcare Services (AMN), Cross Country Healthcare (CCRN), and Biotricity (BTCY). Interpace Biosciences vs. Its Competitors Labcorp Quest Diagnostics DaVita Chemed CorVel Amedisys Pediatrix Medical Group AMN Healthcare Services Cross Country Healthcare Biotricity Labcorp (NYSE:LH) and Interpace Biosciences (NASDAQ:IDXG) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, media sentiment, risk, institutional ownership, earnings and analyst recommendations. Which has more volatility & risk, LH or IDXG? Labcorp has a beta of 0.82, meaning that its share price is 18% less volatile than the S&P 500. Comparatively, Interpace Biosciences has a beta of 0.76, meaning that its share price is 24% less volatile than the S&P 500. Does the media prefer LH or IDXG? In the previous week, Labcorp had 16 more articles in the media than Interpace Biosciences. MarketBeat recorded 16 mentions for Labcorp and 0 mentions for Interpace Biosciences. Labcorp's average media sentiment score of 1.19 beat Interpace Biosciences' score of 0.00 indicating that Labcorp is being referred to more favorably in the media. Company Overall Sentiment Labcorp Positive Interpace Biosciences Neutral Do analysts rate LH or IDXG? Labcorp currently has a consensus target price of $276.08, suggesting a potential upside of 5.42%. Given Labcorp's stronger consensus rating and higher possible upside, analysts clearly believe Labcorp is more favorable than Interpace Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Labcorp 1 Sell rating(s) 2 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 2.79Interpace Biosciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do institutionals and insiders have more ownership in LH or IDXG? 95.9% of Labcorp shares are owned by institutional investors. Comparatively, 5.7% of Interpace Biosciences shares are owned by institutional investors. 0.8% of Labcorp shares are owned by company insiders. Comparatively, 5.5% of Interpace Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Is LH or IDXG more profitable? Interpace Biosciences has a net margin of 10.39% compared to Labcorp's net margin of 5.55%. Labcorp's return on equity of 15.27% beat Interpace Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Labcorp5.55% 15.27% 6.97% Interpace Biosciences 10.39%-8.09%37.14% Which has better earnings and valuation, LH or IDXG? Labcorp has higher revenue and earnings than Interpace Biosciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLabcorp$13.01B1.69$746M$8.6530.28Interpace Biosciences$40.21M0.08$800KN/AN/A SummaryLabcorp beats Interpace Biosciences on 12 of the 15 factors compared between the two stocks. Get Interpace Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IDXG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IDXG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IDXG vs. The Competition Export to ExcelMetricInterpace BiosciencesSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.40M$256.87M$5.53B$9.02BDividend YieldN/AN/A5.22%3.99%P/E RatioN/A5.9227.7920.25Price / Sales0.0873.84430.22119.26Price / Cash1.99196.1226.2128.59Price / Book-0.056.338.035.65Net Income$800K-$27.18M$3.18B$249.15M Interpace Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IDXGInterpace BiosciencesN/A$0.77+0.6%N/A-32.5%$3.40M$40.21M0.00152LHLabcorp4.4608 of 5 stars$264.18+0.6%$276.08+4.5%+28.0%$21.97B$13.01B30.5470,000Positive NewsDGXQuest Diagnostics4.939 of 5 stars$179.36-0.2%$185.73+3.6%+27.3%$20.05B$9.87B22.6856,000Positive NewsDVADaVita4.2891 of 5 stars$146.77+3.0%$164.50+12.1%+4.5%$10.75B$12.82B14.5576,000Positive NewsCHEChemed4.9676 of 5 stars$483.58-0.7%$645.00+33.4%-12.2%$7.12B$2.43B23.5514,200Analyst DowngradeHigh Trading VolumeCRVLCorVel1.007 of 5 stars$104.34+1.5%N/A+19.4%$5.29B$895.59M56.815,075AMEDAmedisys2.704 of 5 stars$96.38-2.0%$100.75+4.5%-1.1%$3.23B$2.35B35.5619,000High Trading VolumeMDPediatrix Medical Group1.6324 of 5 stars$14.33-0.1%$16.67+16.3%+102.3%$1.23B$2.01B-14.194,305AMNAMN Healthcare Services4.2112 of 5 stars$22.00+6.4%$32.08+45.8%-54.8%$791.34M$2.98B-5.082,968Analyst RevisionCCRNCross Country Healthcare3.8744 of 5 stars$13.17+0.9%$17.93+36.1%-3.4%$427.82M$1.34B-24.858,205BTCYBiotricityN/A$0.40+7.6%N/A-45.1%$9.92M$12.06M-0.3740Gap Down Related Companies and Tools Related Companies Labcorp Competitors Quest Diagnostics Competitors DaVita Competitors Chemed Competitors CorVel Competitors Amedisys Competitors Pediatrix Medical Group Competitors AMN Healthcare Services Competitors Cross Country Healthcare Competitors Biotricity Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IDXG) was last updated on 7/7/2025 by MarketBeat.com Staff From Our PartnersA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Interpace Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Interpace Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
